MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

Начало・Списък с акции・Zai Lab Ltd ADR

Search

Zai Lab Ltd ADR

Отворен

СекторЗдравеопазване

20.84 -2.34

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

20.43

Максимум

21.42

Ключови измерители
By Trading Economics
Приходи	-14M -50M
Продажби	12M 128M
Марж на печалбата	-39.506
Служители	1,784
EBITDA	-17M -48M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+63.44% upside

Дивиденти
By Dow Jones
Следващи печалби	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	105M 2.3B
Предишно отваряне	23.18
Предишно затваряне	20.84

Настроения в новините

By Acuity

55%

45%

299 / 349 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

28.13 / 31.12 Подкрепа & съпротива

Zai Lab Ltd ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

8.04.2026 г., 20:44 ч. UTC

Печалби

Costco Reports 11% Growth in March Sales

8.04.2026 г., 23:51 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

8.04.2026 г., 23:51 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8.04.2026 г., 23:36 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Edges Lower on Likely Technical Correction -- Market Talk

8.04.2026 г., 22:56 ч. UTC

Пазарно говорене

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8.04.2026 г., 22:45 ч. UTC

Пазарно говорене

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8.04.2026 г., 22:17 ч. UTC

Пазарно говорене

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8.04.2026 г., 21:52 ч. UTC

Значими събития в новините

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8.04.2026 г., 21:24 ч. UTC

Печалби

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8.04.2026 г., 21:01 ч. UTC

Значими събития в новините

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

8.04.2026 г., 20:43 ч. UTC

Придобивния, сливания и поглъщания

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8.04.2026 г., 20:43 ч. UTC

Придобивния, сливания и поглъщания

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8.04.2026 г., 20:43 ч. UTC

Придобивния, сливания и поглъщания

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8.04.2026 г., 20:42 ч. UTC

Придобивния, сливания и поглъщания

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8.04.2026 г., 20:42 ч. UTC

Придобивния, сливания и поглъщания

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8.04.2026 г., 20:42 ч. UTC

Придобивния, сливания и поглъщания

Oracle Responds to TRC Cap Mini-Tender Offer

8.04.2026 г., 20:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

8.04.2026 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8.04.2026 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8.04.2026 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8.04.2026 г., 19:44 ч. UTC

Печалби

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8.04.2026 г., 19:16 ч. UTC

Пазарно говорене

Hogs Follow Cutout Prices Lower -- Market Talk

8.04.2026 г., 19:02 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

8.04.2026 г., 19:02 ч. UTC

Пазарно говорене

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8.04.2026 г., 18:58 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8.04.2026 г., 18:51 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

8.04.2026 г., 18:51 ч. UTC

Пазарно говорене

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8.04.2026 г., 18:14 ч. UTC

Значими събития в новините

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8.04.2026 г., 18:05 ч. UTC

Значими събития в новините

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Zai Lab Ltd ADR Прогноза

Ценова цел

By TipRanks

63.44% нагоре

12-месечна прогноза

Среден 34.96 USD 63.44%

Висок 47 USD

Нисък 21.8 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Zai Lab Ltd ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

5 ratings

4

Купи

1

Задържане

0

Продай

Според 5 анализатори, дали борсови рейтинги на Zai Lab Ltd ADR през последните 3 месеца.

Техническа оценка

By Trading Central

28.13 / 31.12Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

299 / 349 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.

Други акции от сектора

MDT

Medtronic PLC

88.16

A

Agilent Technologies Inc

115.44

VEEV

Veeva Systems Inc

157.4

HQY

HealthEquity Inc

83.69

TLRY

Tilray Brands Inc

6.71

Live chat